The effect of component of microemulsions on transdermal delivery of buspirone hydrochloride

Journal of Pharmaceutical Sciences

Volumn 100, Issue 6, 2011, Pages 2358-2365

  Tsai, Yi Hung ^a   Chang, Jung Tzu ^a   Chang, Jui Sheng ^a   Huang, Chi Te ^a   Huang, Yaw Bin ^a   Wu, Pao Chu ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Buspirone hydrochloride; Formulation; Hydrophilic lipophilic balance; Microemulsion; Permeability; Skin; Transdermal drug dellivery

Indexed keywords

BRIJ 30; BUSPIRONE; DRUG CARRIER; EXCIPIENT; MACROGOL STEARATE; MYRISTIC ACID ISOPROPYL ESTER; POLIDOCANOL; POLYOXYETHYLENE SORBITAN TRIOLEATE; POLYSORBATE 80; POLYSORBATE 85; SORBITAN LAURATE; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; HYDROPHILICITY; LIPOPHILICITY; MICROEMULSION; NONHUMAN; RAT; SKIN PERMEABILITY; VISCOSITY;

EID: 79954586753     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22474     Document Type: Article

References (31)

1. Gammans RE, Mayol RF, LaBudde JA. 1986. Metabolism and disposition of buspirone. Am J Med 80(3B):41-51.
2. Kastenholz KV, Crismon ML. 1984. Buspirone, a novel nonbenzodiazepine anxiolytic. Clin Pharm 3(6):600-607.
3. Mahmood I, Sahajwalla C. 1999. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 36(4):277-287.
4. Paolino D, Ventura CA, Nistico S, Puglisi G, Fresta M. 2002. Lecithin microemulsions for the topical administration of ketoprofen: Percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm 244(1-2):21-31.
5. Yuan Y, Li SM, Mo FK, Zhong DF. 2006. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm 321(1-2):117-123.
6. Cheng MB, Wang JC, Li YH, Liu XY, Zhang X, Chen DW, Zhou SF, Zhang Q. 2008. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme. J Control Release 129(1):41-48.
7. Fang JY, Wu PC, Fang CL, Chen CH. 2010. Intravesical delivery of 5-aminolevulinic acid from water-in-oil nano/submicron-emulsion systems. J Pharm Sci 99(5):2375-2385.
8. Tsai YH, Lee KF, Huang YB, Huang CT, Wu PC. 2010. In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system. Int J Pharm 388(1-2):257-262.
9. Chen H, Chang X, Weng T, Zhao X, Gao Z, Yang Y, Xu H, Yang X. 2004. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release 98(3):427-436.
10. El Maghraby GM. 2008. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: Effects of cosurfactants. Int J Pharm 355(1-2):285-292.
11. Peltola S, Saarinen-Savolainen P, Kiesvaara J, Suhonen TM, Urtti A. 2003. Microemulsions for topical delivery of estradiol. Int J Pharm 254(2):99-107.
12. Spernath A, Aserin A, Ziserman L, Danino D, Garti N. 2007. Phosphatidylcholine embedded microemulsions: Physical properties and improved Caco-2 cell permeability. J Control Release 119(3):279-290.
13. Osborne DW, Ward AJ, O'Neill KJ. 1991. Microemulsions as topical drug delivery vehicles: In vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol 43(6): 450-454.
14. Piemi MP, Korner D, Benita S, Marty JP. 1999. Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J Control Release 58(2):177-187.
15. Kibbe AH. 2000. Handbook of pharmaceutical excipients. 3rd ed. London: Pharmaceutical Press.
16. ISO13321 IS. 1996. Methods for determination of particle size distribution part 8: Photon correlation spectroscopy. International Organization for Standardization (ISO).
17. Wu H, Ramachandran C, Weiner ND, Roessler BJ. 2001. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int J Pharm 220(1-2):63-75.
18. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. 2007. Quality by design: Understanding the product variability of a self-nanoemulsified drug delivery system of cyclosporine A. J Pharm Sci 96(9):2409-2423.
19. Madhusudhan B, Rambhau D, Apte SS, Gopinath D. 2007. 1-O-alkylglycerol stabilized carbamazepine intravenous o/w nanoemulsions for drug targeting in mice. J Drug Target 15(2):154-161.
20. Chung H, Kim TW, Kwon M, Kwon IC, Jeong SY. 2001. Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system. J Control Release 71(3):339-350.
21. Spernath A, Aserin A. 2006. Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci 128-130:47-64.
22. Wu H, Ramachandran C, Bielinska AU, Kingzett K, Sun R, Weiner ND, Roessler BJ. 2001. Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int J Pharm 221(1-2):23-34.
23. Orafidiya LO, Oladimeji FA. 2002. Determination of the required HLB values of some essential oils. Int J Pharm 237(1-2):241-249.
24. Pasquali RC, Taurozzi MP, Bregni C. 2008. Some considerations about the hydrophilic-lipophilic balance system. Int J Pharm 356(1-2):44-51.
25. Huang YB, Lin YH, Lu TM, Wang RJ, Tsai YH, Wu PC. 2008. Transdermal delivery of capsaicin derivative-sodium nonivamide acetate using microemulsions as vehicles. Int J Pharm 349(1-2):206-211.
26. Rhee YS, Choi JG, Park ES, Chi SC. 2001. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm 228(1-2):161-170.
27. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. 2007. Quality by design: Understanding the formulation variables of a cyclosporine A self-nanormulsified drug delivery systems by Box-Behnken design and desirability function. Int J Pharm 332(1-2):55-63.
28. Alany RG, Rades T, Agatonovic-Kustrin S, Davies NM, Trcker IG. 2000. Effects of alcohols and oils on the phase behaviour of quaternary system. Int J Pharm 196:141-145.
29. Trotta M, Gallarate M, Pattarino F, Carlotti ME. 1999. Investigation of the phase behavior of systems containing lecithin and 2-acyl lysolecithin derivatives. Int J Pharm 190(1):83-89.
30. Wu PC, Huang YB, Lin HH, Tsai YH. 1996. Percutaneous absorption of captopril from hydrophilic cellulose gel through excised rabbit and human skin. Int J Pharm 145:215-220.
31. Kobayashi D, Matsuzawa T, Sugibayashi K, Morimoto Y, Kobayashi M, Kimura M. 1995. Feasibility of use of several cardiovascular agents in transdermal therapeutic system with l-menthol-ethanol system on hairless rat and human skin. Biol Pharm Bull 16:254-258.